Compare Novavax Inc (NVAX) vs ABRDN Physical Gold Shares ETF (SGOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs ABRDN Physical Gold Shares ETF — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while ABRDN Physical Gold Shares ETF trades at $38.89. Which is the better fit depends on your goals.
| NVAX | SGOL | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $11.19 | $51.41 |
52-Week Low | $6.22 | $31.18 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →
